Carl Zeiss Jena GmbH Company Profile

16:26 EST 17th November 2017 | BioPortfolio

Application of screening methods to identify novel drugs. Specialised devices to detect molecular interactions, fluorescent correlation spectroscopy.


Tatzendpromenade 1a


Phone: 49 36 41 64 25 00
Fax: 00 49 36 41 64 27 54

News Articles [322 Associated News Articles listed on BioPortfolio]

Carl Zeiss Jena Mikroskop microscope SM XX mit Okularen und Trafo transformer

EUR 118,00 (30 Gebote)Angebotsende: Freitag Nov-10-2017 20:01:49 CETJetzt bieten | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Carl Zeiss Jena Mikroskop microscope SM XX mit Okula...

ZEISS Invests Over EUR 300 Million in Jena High-Tech Site

ZEISS will invest over €300 million in a new integrated high-tech site. The world’s technology leader in the optics and optoelectronics industries unveiled its plan today in Jena. ...

80X Carl Zeiss Microscope objective

EUR 33.92 (0 Bids)End Date: Tuesday Jul-11-2017 15:16:36 ISTBuy It Now for only: EUR 67.85Buy It Now | Bid now | Add to watch list Biotech365 : 80X Carl Zeiss Microscope objective BioMarketp...

ZEISS Opts for Continuity: CEO Kaschke confirmed until 2020

The Supervisory Board of Carl Zeiss AG has decided to continue the appointment of Dr. Michael Kaschke as President & CEO until 30 June 2020. Kaschke joined the ZEISS Group 25 years ago and has served...

Veracity Innovations acquired by Carl Zeiss Meditec

Carl Zeiss Meditec paid an undisclosed amount for Veracity Innovations, a cloud-based ophthalmological technology developer.  -More- 

36mm Carl Zeiss OPMI microscope eyepiece to 30mm adapter adaptor (x1)

34,95 EURFecha de finalización: sábado ago-19-2017 14:48:57 CESTCómpralo ya por sólo: 34,95 EUR¡Cómpralo ya! | Añadir a lista de seguimiento Biotech365 : 36mm Carl Zeiss OPMI microscope ey...

Analytik Jena Sells AJ Blomesystem

Effective July 1, 2017, Analytik Jena AG is selling all of its shares in AJ Blomesystem GmbH to the GUS Group. The sale of the previously wholly owned subsidiary and provider of comprehensive laborat...

Carl Zeiss Meditec reports 8.3% increase in 9-month revenue

In the first 9 months of its 2016-2017 fiscal year, Carl Zeiss Meditec reported an 8.3% increase in revenue to 864.7 million, or 1.10 per share, compared with 798.6 million, or 0.83 per share, a year ...

PubMed Articles [38 Associated PubMed Articles listed on BioPortfolio]

LASIK for the Correction of High Hyperopic Astigmatism With Epithelial Thickness Monitoring.

To evaluate outcomes of high hyperopic LASIK using the MEL 80 excimer laser (Carl Zeiss Meditec, Jena, Germany).

Clinical Comparison of a Trifocal and a Trifocal-Toric Intraocular Lens Based on the Same Diffractive Platform.

Purpose To evaluate and compare the visual performance of a trifocal and a trifocal-toric intraocular lens (IOL) based on the same diffractive platform. Methods Prospective non-randomized comparative ...

Technique of retinal gene therapy: delivery of viral vector into the subretinal space.

PurposeSafe and reproducible delivery of gene therapy vector into the subretinal space is essential for successful targeting of the retinal pigment epithelium (RPE) and photoreceptors. The success of ...

Carl June Speaks of His Pioneering Efforts That Led to the First Food and Drug Administration-Approved Gene Therapy Product.

Rotavirus vaccine will have an impact in Asia.

Carl Kirkwood and Duncan Steele discuss the evidence supporting rotavirus vaccine deployment in Asian countries.

Clinical Trials [63 Associated Clinical Trials listed on BioPortfolio]

Correction of Myopia Wtih or Without Astigmatism Using the VisuMax™ Femtosecond Laser

The objective of this clinical trial is to evaluate the safety and effectiveness of the Carl Zeiss Meditec VisuMax™ Femtosecond Laser lenticule removal procedure for the reduction or eli...

Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies

The purpose of this study is to compare the newly released Spectral OCT/SLO (OTI, Toronto, Canada) with the Zeiss Stratus OCT (Carl-Zeiss Meditec, Dublin, CA) with regards to the quality o...

Prospective Comparison of Cirrus Versus Stratus Ocular Coherence Tomography for Different Retinal Pathology.

Ocular Coherence Tomography (OCT) is a non-invasive ophthalmologic test that uses reflected, unheated, non-concentrated visible light in order to scan and provide a 2-dimensional topograph...

Intraocular Lens Power Calculation Using Pre- and Intra-operative Measurements

Recently a prototype of a combination of an anterior segment OCT (VISANTE; Carl Zeiss Meditec AG) and an operating microscope (OPMI 200; Carl Zeiss Meditec AG) was introduced that allows m...

Clinical Comparison of Length of Cataract Procedures With Zeiss Lumera Versus Older Zeiss Microscope

Study design will be a mix of retrospective (older Zeiss microscope previously in use at our surgery center) and prospective data collection with the Lumera and Callisto software. The Lum...

Companies [571 Associated Companies listed on BioPortfolio]

Carl Zeiss Vision

Carl Zeiss Vision ( is a global leader in precision optics. With a full line of advanced customized lenses, advanced performance coatings, i.Scription® by ...

Carl Zeiss Jena GmbH

Application of screening methods to identify novel drugs. Specialised devices to detect molecular interactions, fluorescent correlation spectroscopy.

Carl Zeiss Meditec, Inc.

Carl Zeiss Meditec AG (ISIN: DE0005313704) is one of the world’s leading medical technology companies. The company supplies innovative technologies and application-oriented s...


ZEISS is an internationally leading technology enterprise operating in the optics and optoelectronics industries. ZEISS develops and distributes lithography optics, measuring tech...

Carl Zeiss Ltd

Even in its early years, the workshop for precision mechanics and optics opened by Carl Zeiss in Jena in 1846 experienced the beginnings of a boom which was to last for a long time to come. A global ...

More Information about "Carl Zeiss Jena GmbH" on BioPortfolio

We have published hundreds of Carl Zeiss Jena GmbH news stories on BioPortfolio along with dozens of Carl Zeiss Jena GmbH Clinical Trials and PubMed Articles about Carl Zeiss Jena GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Carl Zeiss Jena GmbH Companies in our database. You can also find out about relevant Carl Zeiss Jena GmbH Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record